Post covid 19 pulmonary fibrosis. Is it real threat?

After the COVID-19 outbreak, increasing number of patients worldwide who have survived COVID-19 continue to battle the symptoms of the illness, long after they have been clinically tested negative for the disease. As we battle through this pandemic, the challenging part is to manage COVID-19 sequela...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Deependra Kumar, Sharma, Priya, Kumar, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tuberculosis Association of India. Published by Elsevier B.V. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654356/
https://www.ncbi.nlm.nih.gov/pubmed/34099197
http://dx.doi.org/10.1016/j.ijtb.2020.11.003
Descripción
Sumario:After the COVID-19 outbreak, increasing number of patients worldwide who have survived COVID-19 continue to battle the symptoms of the illness, long after they have been clinically tested negative for the disease. As we battle through this pandemic, the challenging part is to manage COVID-19 sequelae which may vary from fatigue and body aches to lung fibrosis. This review addresses underlying mechanism, risk factors, course of disease and treatment option for post covid pulmonary fibrosis. Elderly patient who require ICU care and mechanical ventilation are at the highest risk to develop lung fibrosis. Currently, no fully proven options are available for the treatment of post inflammatory COVID 19 pulmonary fibrosis.

Ejemplares similares